← Back to Search

Emotion Recognition Training for Schizophrenia Risk

N/A
Recruiting
Research Sponsored by The Royal Ottawa Mental Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between (or equal to) 15-25 years of age
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post treatment (1 month)
Awards & highlights

Study Summary

This trial is testing if an emotion recognition intervention can improve social cognition in people at high risk for schizophrenia.

Who is the study for?
This trial is for young people aged 15-25 who have a sibling or parent with schizophrenia. Participants must speak English fluently and not have an IQ below 70, significant neurological disorders, recent substance abuse, or conditions that would make MRI scans unsafe.Check my eligibility
What is being tested?
The study tests emotion recognition training against active control training to see if it can improve social cognition in youth at high risk of schizophrenia due to family history. The effectiveness will be measured through changes in their ability to recognize emotions and related brain activity.See study design
What are the potential side effects?
Since the interventions involve non-invasive training programs, there are minimal expected side effects. However, participants may experience fatigue or stress during cognitive tasks or discomfort from sitting still during MRI scans.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 15 and 25 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post treatment (1 month)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post treatment (1 month) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in brain activity during emotion recognition tasks from baseline
Change in emotion recognition performance from baseline - PENN Emotion Recognition Test

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Emotion Recognition TrainingExperimental Treatment1 Intervention
Group II: Active Control TrainingActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The Royal Ottawa Mental Health CentreLead Sponsor
18 Previous Clinical Trials
2,060 Total Patients Enrolled
7 Trials studying Schizophrenia
356 Patients Enrolled for Schizophrenia

Media Library

Emotion Recognition Training Clinical Trial Eligibility Overview. Trial Name: NCT04681807 — N/A
Schizophrenia Research Study Groups: Emotion Recognition Training, Active Control Training
Schizophrenia Clinical Trial 2023: Emotion Recognition Training Highlights & Side Effects. Trial Name: NCT04681807 — N/A
Emotion Recognition Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04681807 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do the requirements for this trial include individuals aged 65 or younger?

"According to the study's regulations, only people aged 15-25 are eligible for enrollment."

Answered by AI

How many participants are being recruited for this research endeavor?

"Affirmative, the information available on clinicaltrials.gov confirms that this medical trial is actively seeking enrolment. It was first posted on July 21st 2021 and has recently been updated April 27th 2022. The study needs 36 recruits from a single site to move forward."

Answered by AI

Is this research endeavor still welcoming participants?

"As per clinicaltrials.gov, this medical investigation has opened its recruitment process. It was published on the 21st of July 2021 and most recently updated on April 27th 2022."

Answered by AI

What qualifications must potential participants possess to be accepted into this medical study?

"This study is accepting 36 people aged 15 to 25 who have schizophrenia, schizoaffective disorder, or schizophreniform. Furthermore, they must be able to provide evidence of their diagnosis from either a psychiatrist referral or two reliable informants (using the adapted FIGS questionnaire)."

Answered by AI
~6 spots leftby Oct 2024